$0.2950
-0.02-6.23%
At close: -
$0.3100
0.025.08%
After Hours: Dec 20, 6:58 PM EDT
Revelation Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Revelation Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-08 | $-0.84 | $-2.84 | 70.4 % |
Jun 2024 | 2024-08-09 | $-5.13 | $-1.80 | -185.0 % |
Mar 2024 | 2024-05-10 | $-2.46 | $-1.77 | -39.0 % |
Dec 2023 | 2024-03-22 | $-8.33 | $-13.77 | 39.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Revelation Biosciences (REVB) is scheduled to report earnings on March 21, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
The Actual EPS was $-0.84, which beat the estimate of $-2.84.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.